As the survival rate for CCA is between 5–10%, further studies are necessary to determine if KCNQ1OT1 may be an important new biomarker and therapeutic target in reducing mortality in patients with CCA [59,60]. The gene discussed is KCNQ1OT1; the disease is cholangiocarcinoma.